# Ranibizumab for Diabetic Traction Retinal Detachment

> **NCT01201161** · PHASE2 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 19 (actual)

## Conditions studied

- Diabetic Retinopathy
- Retinal Detachment

## Interventions

- **DRUG:** Ranibizumab
- **OTHER:** Sham injection

## Key facts

- **NCT ID:** NCT01201161
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2010-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01201161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01201161, "Ranibizumab for Diabetic Traction Retinal Detachment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01201161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*